3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Kidney Neoplasms
1
Fatigue
1
Carcinoma, Renal Cell
1
Interventions
Therapeutics
5
Methylphenidate
3
Exercise
3
Sunitinib
2
Psychiatric Rehabilitation
2
Physical Therapy Modalities
2
isoquercitrin
1
enzalutamide
1
darolutamide
1
apalutamide
1
Transcranial Magnetic Stimulation
1
Surveys and Questionnaires
1
Sugars
1
Qigong
1
Nutritional Support
1
Neurofeedback
1
Methods
1
Lactose
1
High-Intensity Interval Training
1
Epoetin Alfa
1
Early Intervention, Educational
1
Dexamethasone
1
Darbepoetin alfa
1
Creatine
1
Counseling
1
Cognitive Behavioral Therapy
1
Acupuncture Therapy
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fatigue
×
isoquercitrin
×
Genitourinary
×
Clear all
NCT02446795
2017-01-18
QUASAR
Consorzio Oncotech
Phase 1/2
Unknown
104 enrolled